TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05101200

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Dose Neural Mobilization Technique
Description: Patients in This Group will receive the high dose neural mobilization along with hot pack, strengthening exercises, Neural mobilization technique (slump, sciatic). Participants in the NMG will be asked to actively perform knee extension, ankle dorsiflexion, and head extension in a slumped posture (body and neck semi flexion) followed by simultaneous ankle plantar flexion together with knee and head flexion, Hot pack for 15 minutes, Strengthening exercises of muscles with 10 /8sets. Strengthening exercises of quadriceps with10 rep/8sets, Static stretching exercise for hamstring muscle with 10 rep/8sets, Group A will be given session of 40 min/day, 2 days/week for 4 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Dose Neural Mobilization Technique
Description: Patients in this Group will receive the same treatment as group A but with less intensity and low dosage. Hot pack: 15 minutes, Strengthening exercises of muscles with 10 rep/4sets, Static stretching exercise for hamstring muscle with 10 rep/4sets. Group B will be given session of 40min/day, 2 days/week for 4weeks.
Study: NCT05592860

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mobile application
Description: participants in intervention group will use smart phone application and update glucose level and investigator will adjust the insulin accordingly

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Daily Diary
Description: participants will use daily diary to record glucose level
Study: NCT04902300

Intervention type: OTHER
Intervention: Data collection
Description: evaluation of internet addiction
Study: NCT06500754

Intervention type: OTHER
Intervention: Ultra-strict gluten-free diet
Description: ultra-strict gluten-free diet (avoiding traces and contamination) under dietitian supervision
Study: NCT06452264

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: game-like computerized activities
Description: game-like computerized activities

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: game-like computerized activities
Description: game-like computerized activities
Study: NCT06270758

Intervention type: DIAGNOSTIC_TEST
Intervention: CT scan at the femur
Description: Additional CT scan which is not part of the standard clinical path

Intervention type: DIAGNOSTIC_TEST
Intervention: CT scan at the femur
Description: Additional CT scan which is not part of the standard clinical path
Study: NCT05389449

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Danicopan
Description: Oral tablet
Study: NCT05947292

Intervention type: PROCEDURE
Intervention: Ultrasound-Guided Fascia Iliaca Compartment Nerve Block
Description: Patient's who receive this intervention will have an ultrasound-guided fascia iliaca compartment nerve block performed in the Emergency Department.
Study: NCT05480319

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EDICARS
Description: The investigators propose to (1) Embed the EDICAS into our hospital information system (HIS) in real-time at ED triage to identify high-risk patients (EDICAS 6+); and (2) Distribute wearable smart wristbands to high-risk patients to augment vital signs monitoring and send alerts based on GBTM results. The detection and intervention components together form the rapid response system, the Emergency Department In-hospital Cardiac Arrest Response System (EDICARS).
Study: NCT04933370

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Stimulation parameters
Description: Different device stimulation parameters

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Stimulation parameters
Description: Different device stimulation parameters
Study: NCT05480319

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Usual care will be assigned to this arm. No additional interventions.
Study: NCT04856657

Intervention type: DEVICE
Intervention: Transcranial alternating current stimulation
Description: The tACS will be applied with a current of 1-2 mA (milliamperes) via two saline soaked electrode sponges (25 cm²) applied to the back of the head. The anode will be located at Oz and the cathode will be located at Cz.

Intervention type: DEVICE
Intervention: Transcranial alternating current stimulation
Description: The tACS will be applied with a current of 1-2 mA (milliamperes) via two saline soaked electrode sponges (25 cm²) applied to the back of the head. The anode will be located at Oz and the cathode will be located at Cz.
Study: NCT05641701

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: System On
Description: The DBS system will be turned on, and the individual's stutter will be assessed.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: System off
Description: The DBS system will be turned off, and the individual's stutter will be assessed.
Study: NCT05253508

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine 2% Injectable Solution
Description: A digital nerve block by injections to the base of the finger
Study: NCT06085976

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Octreotide
Description: A loading dose of 100 mcgr of octreotide will be administered in the intervention group, diluted in 100 ml of SSF to be passed in 30 minutes.~Subsequently, it will be administered in continuous perfusion at 25 mcgr/h in the intervention group.~The drug can be administered through a peripheral or central venous line at the choice of the anesthesiologist, since the drug has a density that allows its administration by both routes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: In the case of the control group, 100 ml of SSF will be administered to be passed in half an hour and then an perfusion of SSF.
Study: NCT05176457

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: communication tool PICT'REA
Description: The pictograms communication tool PICT'REA will be available to patients with invasive ventilation systems preventing them from speaking
Study: NCT05193565

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sirolimus
Description: Orally, once-daily in the morning - Check the blood concentration of Sirolimus at each visit and adjust the dose to achieve the blood concentration maintaining at 3\~8ng/mL

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mycophenolate mofetil
Description: Up to 1g BID(total 2g daily), PO
Study: NCT06416163

Intervention type: OTHER
Intervention: Prospective
Description: Collection of prospective data all ready available for participant
Study: NCT05774327

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Foam Roller
Description: Participants will be shown 7 different foot core exercises and will be instructed to do 10 repetitions 3 times a day. For 6 weeks, in addition to foot core exercises, myofascial release will be applied with foam roller 2 days a week. Myofascial release application areas; thoracolumbal fascia, iliotibial band, hamstring, gastro-soleus, peroneal, plantar fascia.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Foot Core Exercises
Description: Participants will be shown 7 different foot core exercises and will be instructed to do 10 repetitions 3 times a day. Foot core exercises; short foot exercise, toe flexion exercise, heel lift exercise,toe abduction exercise, big toe and other toes extension exercise, front swing exercise, back walking exercises. Participants will do the exercises with the researcher two days a week and the other days follow-up will be provided through the online platform.
Study: NCT05104593

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention tested (CAREPATH)
Description: The intervention tested will be the CAREPATH system. CAREPATH consists of an integrated, patient-centred, flexible and modular system that will provide a viable solution for the improvement of the management of multimorbid elderly patients with Mild Cognitive Impairment or mild dementia, with the help of clinicians. CAREPATH will act on patients and their informal caregivers, and its main objective is to empower multimorbid patients with MCI or mild dementia to manage their health condition together with their informal caregiver by providing assistance and reinforcement to follow their individual care plans, so independence and quality of life will increase for both of them. The intervention will provide a personalized care plan and activities proposal (treatment, activities proposal, lifestyle changes, referrals etc.) to patients and caregivers, considering the various sources of patient data available through the CAREPATH platform, and with the help of clinicians.
Study: NCT04538209

Intervention type: RADIATION
Intervention: Abdominal computed tomography with angiography.
Description: technique of combing a Computed Tomography scan with the injection of dye to create pictures of the portal circulation and portosystemic collaterals veins.
Study: NCT05774327

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Foot Core Exercises
Description: Participants will be shown 7 different foot core exercises and will be instructed to do 10 repetitions 3 times a day. Foot core exercises; short foot exercise, toe flexion exercise, heel lift exercise,toe abduction exercise, big toe and other toes extension exercise, front swing exercise, back walking exercises. Participants will do the exercises with the researcher two days a week and the other days follow-up will be provided through the online platform.
Study: NCT05640401

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endoscopy guided by mixed reality (HoloLens2TM) (HXtend™ software)
Description: Included expert gastrointestinal endoscopists performing diagnostic procedures with mixed reality guidance. All the procedures will be performed by using the HoloLens2TM (Microsoft, Redmond, WA, USA), an ergonomic self-contained holographic device.~HoloLens2TM (Microsoft, Redmond, WA, USA) uses HXtend™ developed software (mdconsgroup, Guayaquil, Ecuador) installed and running on Windows holographic OS. The monitors signals are replicated into holograms by an app developed with the unity Software package (Version 2022.1.22, Unity Technologies, San Francisco, CA, USA).~After each procedure, the researchers will evaluate the device performance along with the acceptance and experience of the endoscopists using this technology.
Study: NCT05119803

Intervention type: DEVICE
Intervention: Spinal Mouse (IDIAG M360 )
Description: This device is an electronic computer-aided measuring december that measures the range of motion of the spine, evaluates the angle and shape of the spine in the sagittal and frontal planes. The device provides data to the computer via Bluetooth, and the measured curvatures are displayed on the computer screen. The method has no medical risks or dangers. The device has two rotating wheels that follow the spinous protrusions of the spine, and the distance and angle measurements are transferred from the device to the computer.

Intervention type: DEVICE
Intervention: Spinal Mouse (IDIAG M360 )
Description: This device is an electronic computer-aided measuring december that measures the range of motion of the spine, evaluates the angle and shape of the spine in the sagittal and frontal planes. The device provides data to the computer via Bluetooth, and the measured curvatures are displayed on the computer screen. The method has no medical risks or dangers. The device has two rotating wheels that follow the spinous protrusions of the spine, and the distance and angle measurements are transferred from the device to the computer.
Study: NCT05006742

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: CB study arm
Description: Included patients are randomized to receive cryobiopsy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: FB-CB study arm
Description: Included patients are randomized to receive forceps biopsy and cryobiopsy within the same session
Study: NCT05950646

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Dexmedetomidine will be infused at a rate of 0.01 ml/ kg/h (0.02 μg/kg/h) from 8 pm in the night before surgery until 8 am in the third morning after surgery.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esketamine
Description: Esketamine will be infused at a rate of 0.01 ml/ kg/h (5 μg/kg/h) from 8 pm in the night before surgery until 8 am in the third morning after surgery.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: Normal saline will be infused at a rate of 0.01 ml/ kg/h from 8 pm in the night before surgery until 8 am in the third morning after surgery.
Study: NCT05321446

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GoHand(TM)
Description: The GoHand(TM) is a therapeutic wearable that provides positive auditory feedback when the wrist and hand moves optimally during execution of dexterity tests and everyday movements.
Study: NCT05119803

Intervention type: OTHER
Intervention: Nine Hole Peg Test
Description: The nine-hole peg test is a simple, fast and manual skill test that has been proven to be valid and reliable in measuring upper limb function in Parkinson's patients. While the patient is sitting, he is asked to insert nine sticks into the holes of the test box with nine holes one by one as fast as possible and remove them back when he is finished

Intervention type: OTHER
Intervention: Nine Hole Peg Test
Description: The nine-hole peg test is a simple, fast and manual skill test that has been proven to be valid and reliable in measuring upper limb function in Parkinson's patients. While the patient is sitting, he is asked to insert nine sticks into the holes of the test box with nine holes one by one as fast as possible and remove them back when he is finished
Study: NCT05166707

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BIXINK OC Free
Description: OC Free is a 6-week ERP-based intervention to deliver Exposure and Response Prevention (ERP) to reduce the anxiety from obsessive thoughts and compulsive rituals.
Study: NCT05136833

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RUTI® vaccine
Description: Each dose of the RUTI® vaccine contains 25 µg of fragmented, purified and liposomed heat-inactivated Mycobacterium tuberculosis bacilli (FCMtb) in a total volum of 0.3mL.

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Normal saline will be used as a placebo.
Study: NCT06332872

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Ivermectin
Description: Oral formulation (3mg tablet) Dosage: 2 single doses of 200 mcg/kg given 7 days apart

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4% dimenticone liquid gel
Description: topical formulation (liquid gel) only 1 application
Study: NCT06266793

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Holmium Laser
Description: Assigned to be treated using the Lumenis Pulse 120H Moses 2.0 Holmium Laser.
Study: NCT06076668

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Patients will receive an intravenous dexmedetomidine infusion of 0.2 mcg/kg/h starting at 9 p.m. The infusion will be halved at 6:00 A.M. and discontinued at 6:15 A.M.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melatonin 3 MG
Description: Patients will receive oral melatonin tablet 3 mg 9:00 p.m.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Patients will receive saline infusion at the same rate of dexmedetomidine infusion and placebo capsule similar to that of melatonin.
Study: NCT06487546

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ergothioneine
Description: This is a 1-arm study in which participants will take ergothioneine daily with dose range of 5 mg to 25 mg daily. Blood levels of ergothioneine will be monitored while taking daily ergothioneine and after ergothioneine is stopped.
Study: NCT06050135

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Roadmap to Parenthood
Description: web-based decision support
Study: NCT06266793

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Thulium Laser
Description: Assigned to be treated using the Olympus Soltive Thulium SuperPulsed Fiber Laser
Study: NCT06050135

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Informational Booklet
Description: web-based informational booklet about young adult cancer survivorship
Study: NCT06229392

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fluzone Quadrivalent
Description: Successive cohorts of participants (3 participants per tumor type per cohort) will each be started on a fixed dose of the influenza vaccine. For the first cohort, patients will receive Fluzone Quadrivalent - (Sanofi Pasteur) - 60mcg/0.5mL (standard dose IT flu shot, or dose level 0) intratumorally on day -6 +/- 1 day and day 0 or 1. For the second cohort, patients will receive Fluzone High-Dose Quadrivalent - (Sanofi Pasteur) - 240mcg/0.7mL (high dose IT flu shot, or dose level 1) intratumorally on day -6 +/- 1 day and day 0 or 1. has context menu
Study: NCT05617521

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Abdominal binder (Revive 3-in-1 Postpartum Recovery Support Belt)
Description: Revive 3-in-1 Postpartum Recovery Support Belt (KeaBabies® Co., CA, USA). An abdominal binder is a kind of elastic abdominal compression device

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Loose abdominal binder (Revive 3-in-1 Postpartum Recovery Support Belt)
Description: Revive 3-in-1 Postpartum Recovery Support Belt (KeaBabies® Co., CA, USA). An abdominal binder is a kind of elastic abdominal compression device. It will be loosened just prior the procedure.
Study: NCT06220006

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pulmonary vein isolation
Description: Catheter ablation

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pulmonary vein isolation
Description: Catheter ablation
Study: NCT05408260

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasonography
Description: Undergo HHUS

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Automated Breast Ultrasound
Description: Undergo ABUS
Study: NCT06393335

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metabolically Armed CD19 CAR-T cells
Description: Each subject receive metabolically armed CD19 CAR- T cells by intravenous infusion.
Study: NCT05653453

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tumor treating fields combined with Gemcitabine hydrochloride and albumin binding paclitaxel
Description: Device: Tumor treating fields Subjects will use tumor treating fields until disease progression or for a maximum of 30 months.~Drug: Gemcitabine hydrochloride and albumin binding paclitaxel Subjects will receive Gemcitabine hydrochloride and albumin binding paclitaxel until disease progression or for a maximum of 30 months.
Study: NCT05729893

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: root canal sealers
Description: different sealer used in obturating root canals (resin and bio ceramic)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: root canal sealers
Description: different sealer used in obturating root canals (resin and bio ceramic)
Study: NCT05653453

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine hydrochloride and albumin binding paclitaxel
Description: Drug: Gemcitabine hydrochloride and albumin binding paclitaxel Subjects will receive Gemcitabine hydrochloride and albumin binding paclitaxel until disease progression or for a maximum of 30 months.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine hydrochloride and albumin binding paclitaxel
Description: Drug: Gemcitabine hydrochloride and albumin binding paclitaxel Subjects will receive Gemcitabine hydrochloride and albumin binding paclitaxel until disease progression or for a maximum of 30 months.
Study: NCT05559307

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Xingnaojing injection
Description: Xingnaojing injection 20 ml+0.9% diluted sodium chloride injection 250ml, IV (in the vein), every 12 hours for 7 days.
Study: NCT05364333

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning
Description: For each cycle of RIPC, a blood pressure cuff will be inflated to the non-dominant arm at 200mmHg for 5 minutes (or at least 50mmHg above the systolic arterial blood pressure) followed by 5 minutes of reperfusion time

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Remote ischemic preconditioning
Description: For each cycle of RIPC, a blood pressure cuff will be inflated to the non-dominant arm at 200mmHg for 5 minutes (or at least 50mmHg above the systolic arterial blood pressure) followed by 5 minutes of reperfusion time
Study: NCT05437705

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Magnetic Stimulation
Description: Transcranial Magnetic Stimulation (TMS) is a non-invasive form of brain stimulation. TMS can influence activity in various brain regions, and it allows researchers to test or modify brain circuit communication. The MagPro X100\* magnetic stimulator and Cool-B65 Butterfly Coil are FDA-approved for rTMS treatments of depression.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation
Description: Transcranial Magnetic Stimulation (TMS) is a non-invasive form of brain stimulation. TMS can influence activity in various brain regions, and it allows researchers to test or modify brain circuit communication. The MagPro X100\* magnetic stimulator and Cool-B65 Butterfly Coil are FDA-approved for rTMS treatments of depression.
Study: NCT05297318

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: hypotension prediction index guided
Description: patients receiving hypotension prediction index monitoring and let the anesthesiologist' alerted the coming intraoperatiobe hypotension

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: without hypotesion prediction index guided
Description: patients receiving usual care without hypotension prediction index monitoring but with usual arterial line care
Study: NCT05237206

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SUPLEXA
Description: PBMC-derived autologous cellular therapy derived through an ex vivo activation procedure, resulting in a cell mixture comprised predominantly of NK, NK-T, and T cells stored in cryogenic media.
Study: NCT05321446

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: GoHand(TM)
Description: The GoHand(TM) is a therapeutic wearable that provides positive auditory feedback when the wrist and hand moves optimally during execution of dexterity tests and everyday movements.